Trade

Watchlist

Portfolio

Message

Set Alert

BSE LIVE NSE LIVE 26 Aug, 2025 12:21 Volume Todays L/H More ×

Reported Standalone quarterly numbers for Bal Pharma are:

Net Sales at Rs 73.75 crore in September 2025 down 1.27% from Rs. 74.70 crore in September 2024.

Quarterly Net Profit at Rs. 0.78 crore in September 2025 down 35.59% from Rs. 1.21 crore in September 2024.

EBITDA stands at Rs. 6.91 crore in September 2025 down 11.86% from Rs. 7.84 crore in September 2024.

Bal Pharma EPS has decreased to Rs. 0.49 in September 2025 from Rs. 0.76 in September 2024.

Bal Pharma shares closed at 81.59 on November 11, 2025 (NSE) and has given -17.09% returns over the last 6 months and -31.89% over the last 12 months.

Bal Pharma Standalone Quarterly Results in Rs. Cr.

See Full Page